Pirfenidone and Hyperbilirubinaemia - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Pirfenidone?
Pirfenidone has active ingredients of pirfenidone. Currently, eHealthMe is studying from 1,946 Pirfenidone users.
What is Hyperbilirubinaemia?
Hyperbilirubinaemia (excess of bilirubin in the blood) is found to be associated with 1,587 drugs and 1,041 conditions by eHealthMe. Currently, we are studying 12,476 people who have Hyperbilirubinaemia.
Do you take Pirfenidone and have Hyperbilirubinaemia?Check whether Hyperbilirubinaemia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Pirfenidone side effects by duration, gender and age:
- Pirfenidone side effects (1,946 reports)
Hyperbilirubinaemia treatments and more:
- Hyperbilirubinaemia (12,476 reports)
All the drugs that are associated with Hyperbilirubinaemia:
All the conditions that are associated with Hyperbilirubinaemia:
How the study uses the data?
The study uses data from the FDA. It is based on pirfenidone (the active ingredients of Pirfenidone) and Pirfenidone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tarpeyo and Filspari drug interaction - 4 seconds ago
- Claritin and Diabetic Nephropathy - 6 seconds ago
- Neurontin and Bone Marrow Disorder - 11 seconds ago
- Nystatin and Rezulin drug interaction - 14 seconds ago
- Apidra and Depression Aggravated - 20 seconds ago
- Diclofenac and Euthyrox drug interaction - 23 seconds ago
- Potassium Chloride and Pentam drug interaction - 27 seconds ago
- Gabapentin and Microangiopathic Haemolytic Anaemia - 33 seconds ago
- Losartan and Tongue Coated - 36 seconds ago
- Sulindac and Zofran drug interaction - 40 seconds ago